Company news
Marker Therapeutics, Inc. (NASDAQ:MRKR) news
Marker Therapeutics, Inc. news releases on 6ix. Latest, Aug 8, 2019: Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results
Press releases — page 3
Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results
August 7, 2019
Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR
July 19, 2019
Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma
July 16, 2019
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
June 19, 2019